Blood pressure after weight loss: do medicines need reviewing?

The problem nobody warned you about

If you have lost significant weight on GLP-1 medication and are on blood pressure medication, there is a meaningful chance your antihypertensive dose is now too high. Weight loss — particularly 10% or more — reduces blood pressure reliably, often by 5–10 mmHg systolic or more. [1] The medication that was correctly dosed before weight loss may now be causing your blood pressure to run too low.

This is not a theoretical risk. Low blood pressure — orthostatic hypotension in particular — causes dizziness on standing, falls risk, fatigue, and impaired exercise tolerance. It is one of the most underrecognised consequences of successful weight loss, because clinicians are more accustomed to managing high blood pressure than to considering whether successful treatment has over-shot.

How much does weight loss affect blood pressure?

Approximately 1 mmHg systolic reduction per kilogram of weight loss is a commonly cited estimate, though individual variation is large. [1] In a person who has lost 15 kg, this equates to a potential systolic reduction of around 15 mmHg — enough to shift someone from well-controlled hypertension to frank hypotension if their medication dose remains unchanged.

GLP-1 medications may also have a modest independent blood pressure-lowering effect beyond weight loss, seen in semaglutide and tirzepatide trial data. [2,3] This means the total blood pressure reduction during treatment may exceed what weight loss alone would predict.

Symptoms of over-treated blood pressure

Dizziness or light-headedness on standing (orthostatic hypotension) is the most common symptom. Others include: fatigue without obvious cause, headaches, reduced exercise tolerance, and feeling cold or faint. These symptoms are often attributed to other causes — the weight loss, the medication, lifestyle changes — when the true explanation is antihypertensive over-treatment.

If you experience these symptoms, check your blood pressure sitting and standing. A drop of more than 20 mmHg systolic on standing is clinically significant and warrants GP review of your blood pressure medication.

When to review: stopping GLP-1 medication

Stopping a GLP-1 agent changes the blood pressure picture again. If weight is regained, blood pressure typically rises. If antihypertensives were reduced during the weight loss phase, they may need to be reintroduced or increased as weight returns. This is a dynamic situation, not a one-time adjustment. It requires monitoring through the transition, not just at each endpoint. A Clinical Data Review can map this against your baseline readings and current medication list.

The 90% who have never had a proper secondary cause workup

Around 90–95% of hypertension is labelled "essential" — meaning no specific cause has been identified. In many cases, this label means the workup was incomplete rather than that no cause exists. Significant weight loss sometimes reveals that blood pressure normalises without medication — suggesting the "essential" hypertension was obesity-related rather than idiopathic. This is clinically important: a patient whose blood pressure normalises with weight loss may not need lifelong antihypertensive medication.

This should be determined systematically, not assumed. It requires measuring blood pressure off medication (under supervision) and checking for secondary causes if blood pressure remains elevated despite weight loss. Read more in Understanding High Blood Pressure.

Practical steps

Check blood pressure at weeks two, four, and eight after stopping GLP-1 medication if you are on antihypertensives. Check sitting and standing. If readings are consistently below 110/70 or symptoms of low blood pressure are present, contact your GP before the next scheduled review. Do not adjust antihypertensive medication independently — particularly ACE inhibitors, beta-blockers, and calcium channel blockers, which have specific stopping considerations.